Researchers are exploring next-generation car t cells that could potentially expand treatment options for solid cancers. These new car t cell designs are being engineered to target hard-to-treat solid tumors, showing promise in this area. The development of these cells is part of a broader effort to advance precision medicine platforms for cancer treatment.